FreeGuest Editorial A long road ahead but every reason to travel with purpose October 09, 2020Vol.46 No.38By Roy A. Jensen and Karen E. Knudsen
Free First-ever TCL-AACI study of the leadership pipeline points to urgent need for more diversity at elite cancer centers October 09, 2020Vol.46 No.38By Matthew Bin Han Ong and Katie Goldberg
Free Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds October 02, 2020Vol.46 No.37By Alexandria Carolan, Katie Goldberg and Matthew Bin Han Ong
Drugs & TargetsFree Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma October 02, 2020Vol.46 No.37
Drugs & TargetsFree Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC October 02, 2020Vol.46 No.37
Drugs & TargetsFree University of Illinois scientists enter licensing deal with Bayer, Systems Oncology October 02, 2020Vol.46 No.37
Drugs & TargetsFree Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors October 02, 2020Vol.46 No.37
Clinical RoundupFree Corticosteroids improve survival in critically ill COVID-19 patients October 02, 2020Vol.46 No.37
Clinical RoundupFree Phase III trial shows Opdivo significantly improves DFS as adjuvant therapy for muscle-invasive urothelial carcinoma October 02, 2020Vol.46 No.37
